Antibiotic Therapies in Maxillofacial Surgery in the Context of Prophylaxis

Table 3

Microorganisms isolated from 484 patients treated at the Cranio-Maxillo-Facial Surgery Chair and Clinic and the Clinical Outpatient Unit for Maxillofacial Surgery.

Microorganism	2008	2008%	2009	2009%	2010	2010%	2011	2011%	2012	2012%	Total
Coagulase (−) Staphylococcus	7	9.09	33	20.37	47	35.07	41	26.62	38	19.10	166
MRSA S.aureus	0	0.00	0	0.00	0	0.00	0	0.00	2	1.01	2
MSSA S.aureus	14	18.18	10	6.17	13	9.70	9	5.84	8	4.02	54
Other G (+) cocci	4	5.19	13	1.23	5	3.73	5	3.25	2	1.01	29
SS. mitis and oralis	7	9.09	11	6.79	11	8.21	24	15.58	29	14.57	82
Other α-haemolytic streptococci	10	12.99	21	12.96	16	11.94	16	10.39	26	13.07	89
Β-haemolytic streptococci	10	12.99	13	8.02	10	7.46	2	1.30	9	4.52	44
Viridans streptococci	3	3.90	8	4.94		0.00	9	5.84	26	13.07	46
Enterococcus	3	3.90	4	2.47	2	1.49	8	5.19	6	3.02	23
Total cocci	58	75.32	113	69.75	104	77.61	114	74.03	146	73.37	535
Other G (+)	0	0.00	2	1.23	1	0.75	1	0.65	2	1.01	6
Total G (+)	58	75.32	115	70.99	105	78.36	115	74.68	148	74.37	541 (74.52%)
E. coli	5	6.49	10	6.17	5	3.73	5	3.25	10	5.03	35
Klebsiella	3	3.90	11	6.79	4	2.99	5	3.25	10	5.03	33
Pseudomonas aeruginosa	3	3.90	1	0.62	1	0.75	0	0.00	4	2.01	9
Enterobacteriaceae	3	3.90	3	1.85	1	0.75	0	0.00	6	3.02	13
Haemophilus	1	1.30	7	4.32	10	7.46	8	5.19	6	3.02	32
Serratia	0	0.00	1	0.62	1	0.75	1	0.65	0	0.00	3
Acinetobacter	1	1.30	3	1.85	2	1.49	1	0.65	4	2.01	11
Proteus	1	1.30	2	1.23	1	0.75	3	1.95	1	0.50	8
Enterobacter	0	0.00	5	3.09	4	2.99	5	3.25	4	2.01	18
Other G (−)	1	1.30	3	1.85	0	0.00	8	5.19	3	1.51	18
Total G (−)	18	23.68	46	35.19	29	21.64	36	23.38	48	22.11	177 (24.38%)
Candida	1	1.30	1	0.62	0	0	3	1.95	3	1.51	8 (1.10%)
Total microorganisms	77	100.00	162	100	134	100	154	100	199	100	726 (100%)

G (+): Gram+ bacteria; G (−): Gram− bacteria.